Latest Hybridoma Technology Stories
MBS acquired an MTI seed grant with the intent to integrate the antibodies into a lateral flow, point of care test to measure both equine progesterone and LH as a method of predicting ovulation
Today, MBS is announcing the release of three monoclonal antibodies to chikungunya virus.
MAB242P, the most recently developed antibody, is the first MBS antibody to recognize both GI and GII strains of norovirus.
CAMBRIDGE, England, June 24, 2014 /PRNewswire/ -- Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization, and provides proprietary
Bacterial recombinant protein expression is now available as a service at Maine Biotechnology Services.
Monoclonal antibodies specific to Rift Valley Fever Virus developed by Maine Biotechnology Services, in partnership with the USDA-Agricultural Research Service, are now available for sampling.
A surprising discovery about the physical properties of cancer cells could help improve a new diagnostic approach—a liquid biopsy—that detects, measures, and evaluates cancer cells in blood.
WHEATON Industries has acquired the CELLine Bioreactor Flask Line for Antibody and Protein Production from Wilson Wolf Manufacturing Corporation Millville, NJ
MENLO PARK, Calif., June 8, 2011 /PRNewswire/ -- ForteBioÂ®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its Dip and Read(TM) Anti-Mouse IgG Fc Capture (AMC) biosensor for use on the company's OctetÂ® instrumentation platform.
BERGISCH GLADBACH, Germany, May 12, 2011 /PRNewswire/ -- Miltenyi Biotec, the only company to offer a seamless experimental integration path from sample preparation through cell separation, culture, and analysis for primary cells, today entered into a strategic alliance with TeutoCell, a provider of cutting edge cell culture technology.